To validate these findings multicenter studies including more patients to investigate the effects of MMP-9 and angiostatin on endothelial dysfunction in FD and to clarify the pathological impact of SDMA accumulation in Fabry associated cardiomyopathy are required. The gene discussed is MMP9; the disease is Fabry disease.